Statera Biopharma Inc. (STAB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.00
-0.00 (-100.00%)
At close: Feb 10, 2025, 9:30 AM
undefined% (undefined)
Bid | n/a |
Market Cap | 7.14K |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.36 |
PE Ratio (ttm) | n/a |
Forward PE | n/a |
Analyst | n/a |
Ask | n/a |
Volume | 200 |
Avg. Volume (20D) | 20,637 |
Open | 0.00 |
Previous Close | 0.00 |
Day's Range | 0.00 - 0.00 |
52-Week Range | 0.00 - 0.13 |
Beta | undefined |
About STAB
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential imm...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 28, 2021
Employees 46
Stock Exchange NASDAQ
Ticker Symbol STAB
Website https://www.staterabiopharma.com